Evidence map›Paper›PMID 42063733›Full record

ArticleFrontiers in oncology2026

Case Report: Interpectoral lymph node metastasis as an indicator of occult breast cancer: a case of double primary malignancy.

Qian Zhao, Yangxuzhu Liu, Yifan Fu, Yuheng Wu, Wei Zhang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qian ZhaoDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Yangxuzhu LiuThe Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
Yifan FuDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Yuheng WuDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Wei ZhangDepartment of Cosmetology Plastic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Occult breast cancer (OBC) is a rare clinical entity, characterized by the presence of metastatic adenocarcinoma in the axillary lymph nodes without an identifiable primary tumor in the breast. We present an unprecedented case of synchronous OBC and primary lung cancer, which initially manifested as an isolated interpectoral (Rotter's) lymph node metastasis. The patient underwent neoadjuvant chemotherapy, followed by wide local excision with sentinel lymph node biopsy, as well as a subsequent wedge resection of the lung primary. The patient declined further recommended adjuvant radiation therapy and genetic testing. Twelve months later, a solitary brain metastasis developed. Histopathological examination confirmed its breast origin, and a craniotomy achieved complete resection. At over 56 months of follow-up, the patient remains recurrence-free. Metastasis to Rotter's lymph node can be the sole inaugural presentation of OBC. Pathological distinction between synchronous primaries is paramount for accurate diagnosis and management. Importantly, multidisciplinary management must address metachronous metastases in the context of treatment non-adherence.

Indexed as

case reportmetachronous brain metastasismultidisciplinary managementmultiple primary cancersneoadjuvant chemotherapyoccult breast cancerRotter’s lymph node metastasis

Identifiers

PMID42063733
PMCPMC13124606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.